Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens - Ph2 OptiMUM-01 Results Coming Up
Tweet Send to a Friend
Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $42.00 price target on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




